Product
[18F]MK-6240
1 clinical trial
1 indication
Indication
Alzheimer diseaseClinical trial
Phase 1 Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's DiseaseStatus: Completed, Estimated PCD: 2023-06-27